SCHEMBL3799851

SCHEMBL3799851

O=C(O)N1CCC(n2c(=O)n(CC3CCCCC3)c3ccccc32)C[C@@H]1CCCN(Cc1ccccc1)Cc1ccccc1.O=C(O)N1CCC(n2c(=O)n(Cc3ccccc3)c3ccccc32)C[C@@H]1CCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 7/20 0.42
▸ OPRM1 P35372 5/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ C5AR1 P21730 3/20 0.41
▸ CYP2D6 P10635 5/20 0.40
▸ CYP3A4 P08684 4/20 0.40
▸ ENPP2 Q13822 1/20 0.37
▸ CACNA1G O43497 2/20 0.37
▸ CACNA1H O95180 2/20 0.37
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4681959 0.97 OPRL1 (0.44) OPRL1OPRM1OPRK1C5AR1CYP2D6
SCHEMBL4800257 0.83 OPRL1 (0.36) OPRL1OPRM1OPRK1CYP2D6CYP3A4
SCHEMBL4675598 0.82 CYP3A4 (0.40) OPRL1OPRM1C5AR1CYP2D6CYP3A4
SCHEMBL4681962 0.81 OPRL1 (0.46) OPRL1OPRM1OPRK1C5AR1ENPP2
SCHEMBL4681961 0.81 OPRL1 (0.46) OPRL1OPRM1OPRK1C5AR1ENPP2
SCHEMBL3398375 0.80 CACNA1G (0.35) C5AR1CYP2D6CYP3A4CACNA1GCACNA1H
SCHEMBL4734750 0.79 DPP7 (0.37) OPRL1OPRM1OPRK1CYP2D6CYP3A4
SCHEMBL3665332 0.79 POLB (0.35) OPRL1OPRM1OPRK1C5AR1CACNA1G
SCHEMBL4804462 0.79 CACNA1G (0.43) OPRL1OPRM1OPRK1C5AR1CYP2D6
SCHEMBL3665336 0.78 CHRM5 (0.36) C5AR1CACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback